• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of February 10, 2016

  • Print
  • Share
  • E-mail

Product Detail

Product Description Lyrica (pregabalin) capsules, 75 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1014-68
Recall Number D-0649-2016
Classification Class II
Code Info Lot #: M07862, Exp 05/2018; M07865, Exp 06/2018
Product Distributed Qty 116,400 bottles
Reason For Recall FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.

Event Detail

Event Id 73043
Product Type Drugs
Status Ongoing
Recalling Firm Pfizer Inc.
City New York
State NY
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2016-01-11
Initial Firm Notification of Consignee or Public Letter
Distribution Pattern Nationwide and Puerto Rico